Xiaohui Wang

Autologous T Cells Expressing CD30 Chimeric Antigen Receptors for Relapsed or Refractory Hodgkin Lymphoma: An Open-Label Phase I Trial

Yang Liu, Yan Zhang, Yao Wang, 2016, Clinical Cancer Research.

Eliminating ovarian cancer stem cells: a potential therapeutic target for ovarian cancer chemoresistance.

Q. Mei, Xiaolei Li, Zhiqiang Wu, 2015, Current protein & peptide science.

The Accomplices of NF-κB Lead to Radioresistance.

Xia Li, Q. Mei, Xiaolei Li, 2015, Current protein & peptide science.

Low Dose Decitabine Combined with Taxol and Platinum Chemotherapy to Treat Refractory/Recurrent Ovarian Cancer: An Open-Label, Single-Arm, Phase I/II Study.

Y. Meng, W. Han, Yao Wang, 2015, Current protein & peptide science.

Elevated microRNA-23a Expression Enhances the Chemoresistance of Colorectal Cancer Cells with Microsatellite Instability to 5-Fluorouracil by Directly Targeting ABCF1.

Xiaobing Fu, Q. Mei, Xiaolei Li, 2015, Current protein & peptide science.

Low-Dose Decitabine-Based Chemoimmunotherapy for Patients with Refractory Advanced Solid Tumors: A Phase I/II Report

W. Han, Yao Wang, Hui Fan, 2014, Journal of immunology research.

Autologous T cells expressing CD30 chimeric antigen receptors for relapsed or refractory Hodgkin's lymphoma: an open-label phase 1 trial

Yao Wang, W. Han, Zhi-qiang Wu, 2015, The Lancet.

CTLA-4 and its inhibitors in esophageal cancer: efficacy of therapy and potential mechanisms of adverse events.

Shenmin Zhang, Xiaohui Wang, Chenrui Tian, 2023, American Journal of Cancer Research.